Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Vaping breakthrough? new pill shows promise in helping adults quit E-Cigarettes

NCT ID NCT05431387

First seen Jan 21, 2026 · Last updated May 24, 2026 · Updated 16 times

Summary

This study tested a medication called cytisinicline to see if it helps adults stop vaping. 160 people who vape daily took either the drug or a placebo for 12 weeks. The main goal was to see if more people could quit vaping by the end of treatment, confirmed by saliva tests.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for E-CIG USE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Alliance for Multispecialty Research, LLC

    Lexington, Kentucky, 40509, United States

  • Alliance for Multispecialty Research, LLC

    Knoxville, Tennessee, 37920, United States

  • Coastal Carolina Research Center

    North Charleston, South Carolina, 29405, United States

  • Massachusetts General Hospital - Clinical Genetic Research Facility

    Boston, Massachusetts, 02114, United States

  • Rochester Clinical Research, Inc

    Rochester, New York, 14609, United States

Conditions

Explore the condition pages connected to this study.